US Stock Market Movement: Eli Lilly Surges on October 7th as Target Price is Raised and Weight Loss Drug Announced
Bitget异动解读2026/10/07 15:20Eli Lilly's Surge on October 7: Analysis
Keywords: Price target raise, weight loss drug
1. On October 7, Morgan Stanley analysts maintained their "Buy" rating on Eli Lilly and raised the price target from $1,419 to $1,430.
2. On October 6, Eli Lilly expanded its collaboration with Gate Bioscience, obtaining exclusive global rights to related products. If development milestones are achieved, the potential payment could exceed $870 million, further expanding its innovative drug pipeline.
(Disclaimer: This content is compiled and summarized by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Nasdaq hits a new high, igniting expectations for the US stock earnings season! Citi predicts nearly 90% of tech stocks will deliver "earnings surprises," with Nvidia and AMD leading the outperformance list.
According to Zhitong Finance APP, following a record high achieved by the Nasdaq Composite Index and a new all-time high for Nvidia, the "AI chip superpower" that holds significant weight in both the Nasdaq and S&P 500 indexes, the U.S. stock market is about to kick off its Q3 earnings season. Global investors are becoming increasingly enthusiastic about the possibility that U.S. companies’ revenue and profits will exceed expectations, especially among tech giants closely associated with AI computing power, whose performance may surpass analysts' forecasts.
Porsche plans to increase the average price of its top models by about 20% before 2030.
Porsche plans to increase the average price of its most expensive models by about 20% by 2030, emulating Ferrari’s strategy of boosting profits by enhancing product exclusivity. On Wednesday, Porsche CEO Oliver Blume announced during an Investor Day event a multi-year revitalization plan aimed at reviving performance by reducing vehicle sales and shifting toward higher-end models. Blume stated: “We want to further elevate our brand positioning, maintain Porsche’s uniqueness, and enhance our pricing power.” By 2030, the average price of Porsche’s top models will rise from around €270,000 this year to more than €330,000. Meanwhile, the share of top models in its product portfolio is expected to increase from roughly one-third to 45%. Blume’s strategy will significantly reduce Porsche’s business scale, lowering the number of vehicles required for profitability to under 200,000 units. On Wednesday, Porsche maintained its targets of achieving a 10% to 15% operating profit margin and a maximum net cash flow margin for its automotive business of up to 12% by 2030. The company also plans to reach a 15% profit margin by 2035.
Brent crude oil main futures contract surpasses $105 per barrel, up 4.07% intraday
The main contract of Brent crude oil futures has just surpassed the $105.00 per barrel mark, last trading at $105.01 per barrel, up 4.07% on the day.
Brent crude oil futures main contract rises 4% intraday, quoted at $104.94 per barrel.
The main Brent crude oil futures contract rose by 4.00% during the day, trading at $104.94 per barrel.
Crypto prices
More
